Jazz Pharmaceuticals (JAZZ) Return on Capital Employed Growth (1y) (2012 - 2026)
Jazz Pharmaceuticals (JAZZ) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 2,400.00 |
| 10 | Jazz Pharmaceuticals | 15.81 Bn | 13.96 Bn | 934.80 Mn | -603.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -603.00 |
| Dec 31, 2025 | -1,110.00 |
| Sep 30, 2025 | -1,158.00 |
| Jun 30, 2025 | -890.00 |
| Mar 31, 2025 | 34.00 |
| Dec 31, 2024 | 53.00 |
| Sep 30, 2024 | 402.00 |
| Jun 30, 2024 | 529.00 |
| Mar 31, 2024 | 556.00 |
| Dec 31, 2023 | 660.00 |
| Sep 30, 2023 | -48.00 |
| Jun 30, 2023 | -189.00 |
| Mar 31, 2023 | -112.00 |
| Dec 31, 2022 | -215.00 |
| Sep 30, 2022 | 5.00 |
| Jun 30, 2022 | -275.00 |
| Mar 31, 2022 | -1,154.00 |
| Dec 31, 2021 | -509.00 |
| Sep 30, 2021 | -237.00 |
| Jun 30, 2021 | 120.00 |